Pemafibrate

CHEMBL247951 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

490.5 g/mol

LogP

6.2

Phase

4

A selective peroxisome proliferator-activated receptor alpha (PPARα) agonist used in Japan to lower elevated triglyceride levels in patients with dyslipidemia. It is more selective than older fibrates, potentially offering a more favorable safety profile.

Peso molecular

490,5000 g/mol

LogP

6,20

TPSA

94,30 Å²

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Enfermedad del hígado graso no alcohólico Hiperlipidemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC[C@@H](Oc1cccc(CN(CCCOc2ccc(OC)cc2)c2nc3ccccc3o2)c1)C(=O)O

InChI

InChI=1S/C28H30N2O6/c1-3-25(27(31)32)35-23-9-6-8-20(18-23)19-30(28-29-24-10-4-5-11-26(24)36-28)16-7-17-34-22-14-12-21(33-2)13-15-22/h4-6,8-15,18,25H,3,7,16-17,19H2,1-2H3,(H,31,32)/t25-/m1/s1

Molecular Formula

C28H30N2O6

HBD / HBA

1 / 8

Enlaces Rotables

13

Átomos Pesados

36

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A selective peroxisome proliferator-activated receptor alpha (PPARα) agonist used in Japan to lower elevated triglyceride levels in patients with dyslipidemia. It is more selective than older fibrates, potentially offering a more favorable safety profile.

Yes, Pemafibrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL247951. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 11526038. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

¿Busca información accesible para el paciente?

Pemafibrate en PillFYI

Estructura

Datos Rápidos

Fórmula: C28H30N2O6

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.